Cytokinetics Announces Five Aficamten Presentations at ESC Congress 2025
Cytokinetics will present data from several aficamten trials at the upcoming European Society of Cardiology (ESC) Congress 2025, including...
eClinical Tech News
Sionna Therapeutics Doses First Subjects in Phase 1 Cystic Fibrosis Trial
Sionna Therapeutics has initiated dosing in a Phase 1 trial evaluating dual combinations of its lead candidate, the NBD1...
Argenx’s Vyvgart Shows Promise in AChR-Ab Seronegative gMG Patients
Argenx’s efgartigimod met its primary endpoint in the ADAPT SERON trial, demonstrating a statistically significant improvement in MG-ADL scores...
Blossomhill Doses First Patient in Expanded Phase 1/2 Solara Trial Cohorts
BlossomHill Therapeutics has initiated dosing in the expansion cohorts of its Phase 1/2 SOLARA trial evaluating BH-30643, a novel...
Scilex CEO to Focus on Semnur’s SP-102 for Sciatica Treatment
Semnur Pharmaceuticals, a majority-owned subsidiary of Scilex Holding Company, has secured a $20 million private placement to fund the...
Global Knee Replacement Surgery Market to Surpass $16B by 2030
The global knee replacement surgery market is projected to reach $16.17 billion by 2030, expanding at a 6.1% compound...
Septerna Doses First Participants in Sep-631 Phase 1 Trial
Septerna has dosed the first participants in a Phase 1 trial of SEP-631, an oral, selective, small molecule Mas-related...
Nurexone Biologic Shows Preclinical Spinal Cord Repair with Exopten
NurExone Biologic Inc. has released new preclinical MRI-DTI (Diffusion Tensor Imaging) data for ExoPTEN, its exosome-based therapy for spinal...
Hutchmed Completes Patient Enrollment for Orpathys®-Tagrisso® Lung Cancer Trial in China
Hutchmed has completed enrollment in its China Phase 3 SANOVO trial, evaluating the combination of savolitinib (Orpathys) and osimertinib...
Hutchmed Enrolls First-Line Lung Cancer Patients in China Trial
HUTCHMED has completed enrollment in its China Phase III SANOVO trial evaluating savolitinib plus osimertinib as a first-line treatment...